Are all alpha-blockers created the same?

European Urology

Volumn 49, Issue 3, 2006, Pages 420-422

  Irani, Jacques ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; DOXAZOSIN; PHENYLEPHRINE; PLACEBO; TAMSULOSIN; TERAZOSIN;

CLINICAL TRIAL; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HUMAN; MEDICAL SOCIETY; META ANALYSIS; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RETROGRADE EJACULATION; SIDE EFFECT; SMOOTH MUSCLE; SYSTEMATIC REVIEW;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; CLINICAL TRIALS; DIZZINESS; DOXAZOSIN; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUINAZOLINES; SULFONAMIDES;

EID: 32944464494     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.032     Document Type: Editorial

References (10)

1. M. Marberger, R. Harkaway, and J. de la Rosette Optimising the medical management of benign prostatic hyperplasia Eur Urol 45 2004 411 419
2. American Urological Association. AUA guideline on the management of benign prostatic hyperplasia. 2003. Available from URL: www.auanet.org/timssnet/ products/guidelines/bph_management.cfm.
3. B. Djavan, C. Chapple, S. Milani, and M. Marberger State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Urology 64 2004 1081 1088
4. B. Djavan, and M. Marberger A meta-analysis on the efficacy and tolerability of alpha 1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction Eur Urol 36 1999 1 13
5. R. MacDonald, and T.J. Wilt Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects Urology 66 4 2005 Oct 780 788
6. J.D. McConnell, C.G. Roehrborn, O.M. Bautista, G.L.J. Andriole, C.M. Dixon, and J.W. Kusek The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387 2398
7. R.S. Kirby, C.G. Roehrborn, P. Boyle, G. Bartsch, A. Jardin, and M.M. Cary Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the prospective European doxazosin and combination therapy (PREDICT) trial Urology 61 2003 119 126
8. J. Nordling Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia BJU Int 95 2005 1006 1012
9. M. Michel, and C. Chapple Comparison of the cardiovascular safety of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged released (XL) Eur Urol 49 2006 501 509
10. T. Nieminen, R. Ylitalo, T. Kööbi, P. Ylitalo, and M. Kähönen The vasodilatory effect of alfuzosin and tamsulosin in passive orthostasis: a randomised, double-blind, placebo controlled study Eur Urol 47 2005 340 345